New Medicines Restore Heart Function in 25 Percent of Heart Failure Patients
Nagpur: In a groundbreaking development, new medicines are helping 1 in 4 heart failure patients regain normal heart function, according to experts at the Annual ECHO Nagpur 2025 Conference.
"Heart failure is no longer a hopeless diagnosis. With modern treatments, we can now reverse the condition in about 25% of patients, restoring the heart's ability to pump blood efficiently. Additionally, in 50% of cases, heart failure can be managed effectively to improve quality of life," said Dr. JC Mohan, a leading cardiologist.
Heart failure, which affects nearly 1 crore adults in India, is often misunderstood. Unlike a heart attack, which occurs suddenly due to a blockage, heart failure develops gradually as the heart weakens over time. Sadly, it has a worse prognosis than many cancers, often going undiagnosed until it becomes severe.
Dr. Mohan emphasized the importance of early detection and treatment, which can extend patients' lives by six to eight years. Simple tests such as ECHO, ECG, and blood work can help identify heart failure early.
Dr. Vinod Vijan, former president of the Lipid Association of India, stressed the need for lower cholesterol levels among Indians due to their genetic vulnerability to heart diseases. He recommended aiming for cholesterol levels 10 points below global standards.
Dr. Shantanu Sengupta highlighted that awareness has grown significantly in the last two decades. Tools like 2D and 3D ECHO have become crucial in detecting early-stage heart problems, and he suggested people over 40 include these tests in regular health check-ups.
This breakthrough offers hope for millions, but experts caution that early diagnosis and lifestyle changes remain critical to combating heart failure effectively.
2026-08-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Japan Extends Bisphenol A Anti-Dumping Probe, Prolonging Uncertainty for Korean and Taiwanese Suppliers
-
Kemira to Acquire Water Engineering for USD 150 Million
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
U.S. 10% Temporary Tariff Expires, New Section 301 Tariffs Not Yet Implemented
-
“Zero Tariff Is Not a Get-Out-of-Jail-Free Card”: Hainan’s Full Customs Closure—Boon or Trap for the Chemical Industry?
Recommend Reading
-
"No available slots" returns as global shipping rates skyrocket amid multiple factors
-
Sika in China Under Pressure: The Structural Alarm Behind the 1,500-Job Cut
-
Iran's Only MDI/TDI Plant Attacked, Middle East Supply Nearly Zero, Global Gap Widens
-
Keshun Enters Industrial Coatings: Waterproofing Leader Seeks Growth Beyond Real Estate
-
Why Did Chemical Raw Materials Unexpectedly Escape the Latest Round of U.S. 301 Tariffs on 60 Economies?
-
October Natural Rubber Market Fluctuates, Shows Slight Increase Overall
-
June Acetic Acid Market Trends: First Decline, Then Rise
-
In October, the Shandong asphalt market saw a significant decline
-
Cyclohexane Market in Low Demand Season with High Inventory Levels
-
Costs Continue to Decline as October Styrene-Butadiene Rubber Market Weakens and Falls